What dexamethasone dose is used to suppress cortisol for low‑dose and high‑dose suppression tests and for therapeutic treatment?

Dexamethasone Dosing for Cortisol Suppression Testing and Treatment

Diagnostic Suppression Testing Doses

For screening Cushing's syndrome, the standard overnight dexamethasone suppression test uses 1 mg of dexamethasone given orally between 11 PM and midnight, with serum cortisol measured at 8 AM the following morning. 1 Normal suppression is defined as serum cortisol <1.8 μg/dL (50 nmol/L), which has >90% sensitivity for detecting Cushing's syndrome. 1, 2

Low-Dose Dexamethasone Suppression Test (LDDST)

• The 2-day LDDST protocol involves 0.5 mg dexamethasone orally every 6 hours for 48 hours (total 4 mg over 2 days), with cortisol measurement at 0,24, and 48 hours. 1
• Normal response is suppression to <1.8 μg/dL (50 nmol/L). 1, 3
• This test has lower sensitivity than the overnight 1 mg test, with false-negative rates of 28-38% in confirmed Cushing's syndrome. 4

Alternative Low-Dose Screening

• A 0.25 mg overnight dose may identify some patients with mild Cushing's syndrome who suppress to the standard 1 mg dose. 5
• Morning cortisol >7.6 μg/dL after 0.25 mg dexamethasone warrants further testing. 5
• However, this ultra-low dose is not yet incorporated into standard guidelines and should be considered investigational. 5

High-Dose Dexamethasone Suppression Test

• The traditional high-dose test uses 8 mg dexamethasone overnight or 2 mg every 6 hours for 48 hours (total 8 mg). 6
• Critical pitfall: This test is used only to differentiate pituitary from ectopic ACTH sources after Cushing's syndrome is confirmed, never for initial diagnosis. 1
• A very high dose protocol (32 mg over 24 hours) has been studied but is not recommended in standard guidelines. 6

Therapeutic Glucocorticoid Equivalency

In therapeutic contexts, 0.1 mg dexamethasone is roughly equivalent to 2.0 mg prednisolone and 10 mg hydrocortisone. 7 This means:

• 8 mg dexamethasone = 200 mg hydrocortisone in terms of glucocorticoid potency and duration. 7
• Dexamethasone has a much longer biological half-life than hydrocortisone, which accounts for its higher relative potency despite the dose equivalency. 7

Adrenal Suppression from Therapeutic Doses

• Daily glucocorticoid doses equivalent to prednisolone ≥5 mg for longer than 1 month represent an adrenal suppressive dose in a significant proportion of adults. 7
• Approximately one-third to one-half of patients receiving 5-20 mg prednisolone daily fail to achieve target cortisol on short synacthen testing, indicating inadequate adrenal reserve. 7

Key Pharmacologic Considerations

Dexamethasone Metabolism and Test Validity

• CYP3A4 inducers (phenobarbital, carbamazepine, St. John's wort) accelerate dexamethasone clearance, causing false-positive suppression tests. 1, 2
• CYP3A4 inhibitors (fluoxetine, cimetidine, diltiazem) slow dexamethasone metabolism, causing false-negative results. 1
• Measuring dexamethasone levels concomitantly with cortisol reduces false-positive results by confirming adequate drug exposure; levels <1.8 ng/mL (4.6 nmol/L) suggest inadequate absorption. 1, 2

Oral Contraceptives and Estrogen

• Oral estrogen-containing medications increase cortisol-binding globulin (CBG), raising total cortisol measurements while free cortisol remains normal. 3, 2
• The DST may be less reliable in women taking oral contraceptives due to altered cortisol binding. 2

Diagnostic Algorithm for Borderline Results

When post-dexamethasone cortisol falls in the borderline range (1.8-5.0 μg/dL):

• Measure post-test dexamethasone level to identify false-positives from rapid metabolism or malabsorption. 1
• Obtain 2-3 additional screening tests including 24-hour urinary free cortisol and late-night salivary cortisol to account for cyclic Cushing's syndrome. 1
• Do not escalate to high-dose testing—this range represents a diagnostic gray zone requiring additional first-line screening, not differential testing. 1

Critical Pitfall to Avoid

Some patients with confirmed Cushing's disease (8-18%) suppress serum cortisol to <5 μg/dL after 1 mg dexamethasone, and 8% suppress to <2 μg/dL. 4 This means low-dose dexamethasone tests should never be used as the sole criterion to exclude Cushing's syndrome. 4 The 2-day LDDST has even higher false-negative rates (28-38%). 4

Neonatal Dosing Context

In neonates being treated for bronchopulmonary dysplasia:

• Low-dose dexamethasone is defined as <0.2 mg/kg/day. 7
• High-dose dexamethasone is approximately 0.5 mg/kg/day. 7
• High doses have been associated with neurodevelopmental impairment and should be avoided. 7